Posts Tagged ‘pharmaceutical industry’

Rx Drugs: Timed-Release Bribery?

July 9, 2018

Rx Drugs: Timed-Release Bribery?

“An analysis by the publication Science has ‘found widespread after-the-fact payments or research support’ from pharmaceutical companies to expert officials who advised the Food and Drug Administration to approve those companies’ drugs.”

— “Pharma companies pay FDA advisers after drugs are approved,” Bob Herman, Axios

More:

“Hidden conflicts? Pharma payments to FDA advisers after drug approvals spark ethical concerns,” Charles Piller and Jia You, Science

“Majority of doctors who oversee FDA drug approval receive payments from companies they monitor, report shows,” Clark Mindock, The Independent

____________

Short link: https://wp.me/p6sb6-rUa

Top image by Mike Licht. Download a copy here. Creative Commons license; credit Mike Licht, NotionsCapital.com

Comments are welcome if they are on-topic, substantive, concise, and not boring or obscene. Comments may be edited for clarity and length.

Marketing to Doctors

February 28, 2018

 Marketing & Doctors

A while back, John Oliver explained how Big Pharma markets to doctors so they’ll prescribe brand name drugs to patients. As we face another year of corporate deregulation and health care uncertainty, it bears another look:

(more…)

Don’t Worry, There’s a Cure

May 11, 2011

Don't Worry, There's a Cure

At last, a treatment for Dysphoric Social Attention Consumption Deficit Anxiety Disorder. Ask your doctor.

Image by Mike Licht. Download a copy here. Creative Commons license; credit Mike Licht, NotionsCapital.com

Comments are welcome if they are on-topic, substantive, concise, and not boring or obscene. Comments may be edited for clarity and length.

Add to: Facebook | Digg | Del.icio.us | Stumbleupon | Reddit | Blinklist | Twitter | Technorati | Yahoo Buzz | Newsvine

Docs and Disclosure

April 11, 2010

Docs and Disclosure

Drug giant Pfizer paid $20 million in consulting and speaking fees to 4,500 medical professionals in the last six months of 2009.  The corporation, America’s biggest drug company, also paid $15.3 million to U.S. university medical centers for clinical trials of drug products. Corporate disclosure of payments to the people who decide which drugs to recommend is a good thing. right?

Not necessarily, says behavioral economist Dan Ariely. The court-mandated disclosures are designed to reduce conflicts of interest,  but may have the opposite effect:

(more…)